SBC Medical Group (NASDAQ:SBC) Stock Price Down 3.4% – What’s Next?

SBC Medical Group Holdings Incorporated (NASDAQ:SBC)’s share price traded down 3.4% during mid-day trading on Tuesday . The stock traded as low as $4.82 and last traded at $4.9640. Approximately 60,345 shares changed hands during trading, a decline of 44% from the average daily volume of 107,801 shares. The stock had previously closed at $5.14.

Analyst Upgrades and Downgrades

SBC has been the subject of several recent research reports. BTIG Research restated a “buy” rating and issued a $8.00 price target on shares of SBC Medical Group in a report on Thursday, August 13th. Wall Street Zen raised shares of SBC Medical Group from a “buy” rating to a “strong-buy” rating in a report on Saturday. Finally, Weiss Ratings reissued a “sell (d+)” rating on shares of SBC Medical Group in a research note on Wednesday, August 19th. Two research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat, SBC Medical Group currently has a consensus rating of “Hold” and an average target price of $8.50.

SBC Medical Group Price Performance

The company has a market cap of $498.41 million, a PE ratio of 10.31 and a beta of 0.63. The company has a quick ratio of 3.27, a current ratio of 3.31 and a debt-to-equity ratio of 0.09. The firm has a 50 day simple moving average of $3.70 and a 200-day simple moving average of $3.54.

SBC Medical Group (NASDAQ:SBC) last released its quarterly earnings results on Thursday, August 13th. The company reported $0.10 EPS for the quarter, missing the consensus estimate of $0.12 by ($0.02). SBC Medical Group had a net margin of 27.99% and a return on equity of 18.47%. The firm had revenue of $49.19 million for the quarter, compared to analysts’ expectations of $45.37 million. As a group, research analysts predict that SBC Medical Group Holdings Incorporated will post 0.44 earnings per share for the current fiscal year.

Institutional Investors Weigh In On SBC Medical Group

Several institutional investors have recently bought and sold shares of SBC. Citadel Advisors LLC purchased a new position in SBC Medical Group in the second quarter worth $446,000. Two Sigma Securities LLC purchased a new stake in shares of SBC Medical Group during the 2nd quarter valued at $66,000. Bank of America Corp DE purchased a new stake in shares of SBC Medical Group during the 2nd quarter valued at $35,000. BlackRock Inc. acquired a new stake in shares of SBC Medical Group in the 2nd quarter worth $2,846,000. Finally, Deutsche Bank AG acquired a new stake in shares of SBC Medical Group in the 2nd quarter worth $58,000. 60.82% of the stock is currently owned by institutional investors and hedge funds.

About SBC Medical Group

SBC Medical Group (NASDAQ: SBC) is a Japan-based medical services and management company focused primarily on the aesthetic medicine sector. Through its affiliated medical corporations and clinic network, the company supports the operation of facilities offering cosmetic surgery, cosmetic dermatology and related elective treatments.

The company provides a range of management and operational services to affiliated clinics, including branding and marketing, staff recruitment and training, purchasing, information technology, administrative support and business consulting.